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JLong-term objectives associated with cancer survivors have been suggested by Healthy People 2020,
including increasing the proportion of survivors living beyond 5 years after diagnosis and improving
survivors’ mental and physical health-related quality of life. Prior to reaching these objectives,
several intermediate steps must be taken to improve the physical, social, emotional, and ﬁnancial
well-being of cancer survivors. Public health has a role in developing strategic, actionable, and
measurable approaches to facilitate change at multiple levels to improve the lives of survivors and
their families. The social ecological model has been used by the public health community as the
foundation of multilevel intervention design and implementation, encouraging researchers and
practitioners to explore methods that promote internal and external changes at the individual,
interpersonal, organizational, community, and policy levels. The survivorship community, including
public health professionals, providers, policymakers, survivors, advocates, and caregivers, must work
collaboratively to identify, develop, and implement interventions that beneﬁt cancer survivors. The
National Action Plan for Cancer Survivorship highlights public health domains and associated
strategies that can be the impetus for collaboration between and among the levels in the social
ecological model and are integral to improving survivor outcomes. This paper describes the Public
Health Action Model for Cancer Survivorship, an integrative framework that combines the National
Action Plan for Cancer Survivorship with the social ecological model to demonstrate how
interaction among the various levels may promote better outcomes for survivors.
(Am J Prev Med 2015;49(6S5):S470–S476) Published by Elsevier Inc. on behalf of American Journal of
Preventive Medicine. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Healthy People 2020 Objectives for Cancer
SurvivorshipThe deﬁnition of a cancer survivor includes indi-viduals from the point of a cancer diagnosisthroughout the reminder of their life.1 In the
U.S., there are nearly 14 million cancer survivors,2 many
of whom face health-related quality of life (QOL)
concerns (physical, emotional, psychosocial, spiritual,
and ﬁnancial) associated with their diagnosis and sub-
sequent treatment.3,4 In order to address these concerns
and realize improvements in their overall health, Healthy
People 2020 (HP 2020) has set two objectives related to
cancer survivors. HP 2020 objective C-13 aims to
increase the percent of cancer survivors living 5 yearsision of Cancer Prevention and Control, CDC, Atlanta,
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This is an open access article under the CC BY-NCor longer after diagnosis.5 HP 2020 objective C-14 aims
to improve the mental and physical health status among
cancer survivors.5 This latter objective is developmental
and does not currently have national baseline data. Its
inclusion, however, underscores the need to make invest-
ments in interventions that improve the QOL of cancer
survivors.
Public health has an important role in advancing the
nation toward the fulﬁllment of these objectives and
improving the overall health and QOL of cancer survi-
vors. Achieving important intermediate outcomes and
more distal objectives will require collaboration between
and among survivors, communities, organizations, and
policymakers. Key components of public health, such as
the use of key partnerships to facilitate the development
of strategic, actionable, and measureable approaches to
improving the health and QOL of cancer survivors, are
also essential to this effort. Although “The Action Model
to Achieving HP 2020 Goals” serves as a framework for
addressing HP 2020 objectives and achieving desired
outcomes through an ecological approach, achieving
objectives related to cancer survivors may beneﬁt from
additional components speciﬁc to public health actionsevier Inc. on behalf of American Journal of Preventive Medicine.
-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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describes:1.Desocial ecological approaches used to drive public
health action in cancer survivorship;2. the National Action Plan for Cancer Survivorship
(NAPCS), which offers strategies to address the needs
of cancer survivors; and3. an innovative model, the Public Health Action Model
for Cancer Survivorship (PHAM-CS), which com-
bines both the social ecological model (SEM) and
NAPCS domains to address HP 2020 cancer survivor
objectives.
Social Ecological Approaches to Inﬂuence Health
Numerous behavioral, anthropological, and health
models have been used as frameworks to drive public
health action. The SEM, developed by Bronfrenbrener8
and McLeroy et al.,9 articulates a framework for under-
standing the reciprocal interrelationships between indi-
vidual and population-level determinants of behavior.
The model describes factors inﬂuencing behavior at
multiple levels, including the:1. individual level, which embodies characteristics of one
person’s knowledge, attitudes, behavior, developmen-
tal history, demographic characteristics (gender, race/
ethnicity, economic status), and health literacy;2. interpersonal level, where social networks and support
systems include family members, coworkers, and
friends;3. organizational/institutional level, pertaining to char-
acteristics of social institutions with organizational
characteristics and operational rules and regulations;4. community level, which involves relationships among
organizations, institutions, and informational net-
works within deﬁned boundaries; and5. policy level, which pertains to local, state, national,
and global laws and policies.8,9
Adaptations of the SEM have been used by many
public health organizations, including CDC, as a frame-
work for facilitating behavior change related to mental
and physical health.10 Cancer-speciﬁc adaptations of the
SEM have also served as a roadmap to multilevel
intervention design and implementation by encouraging
and supporting change at the individual, interpersonal,
organizational, community, and policy levels.11,12
These models have been used to promote cervical13,14
and colorectal cancer screening,15 improve human
papillomavirus vaccination uptake,16 and reduce
indoor tanning among adolescents17 by enhancingcember 2015communication, commitment, and collaboration among
stakeholders at all levels. To date, however, no model has
addressed the unique needs of cancers survivors and
supplied a framework for public health action at the
multiple levels. The model described here is an innova-
tive attempt at providing a framework to address the
public health needs of survivors. This model uses the
SEM to acknowledge the complex and multilevel system
of inﬂuences on the survivor. It also proposes that the
NAPCS domains encourage collaborative work across
these levels.Domains for Public Health Action: The
National Action Plan for Cancer
Survivorship
The NAPCS identiﬁes public health strategies that are
positioned to address many of the needs of cancer
survivors and their families.3 Ninety-six strategies are
grouped into four public health domains: surveillance
and applied research; communication, education, and
training; programs, policies, and infrastructure; and
access to quality care and services, as well as a ﬁfth
crosscutting domain to provide an integrated and multi-
disciplinary public health roadmap for improving cancer
survivorship.3 A recent assessment of organizational
implementation of the NAPCS strategies related to these
domains demonstrated that these are substantially
addressed by some of the nation’s leading public health
and cancer survivorship organizations. Some additional
areas, however, such as developing clinical guidelines and
assuring a quality workforce, require additional attention
and reﬂect strategies more appropriate for organizations
that provide clinical service delivery.18 The assessment
also found that an increased emphasis on evaluation and
translation of research to practice were warranted—a
particular strength of public health organizations.18
There is a unique opportunity to integrate the SEM
and NAPCS to provide an integrated model for public
health action for cancer survivorship that is strategic,
comprehensive, actionable, and measurable.Overview of the Public Health Action Model for
Cancer Survivorship
The PHAM-CS represents how the NAPCS strategies can
be operationalized to promote collaboration; some strat-
egies include intrapersonal and interpersonal networks of
survivors, organizations, community advocacy and pro-
grammatic groups, and policymakers (Figure 1). The
PHAM-CS was generated using components of adapted
SEMs13–16 and was further expanded to include NAPCS-
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Figure 1. Public health action model for cancer survivorship (PHAM-CS).
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tional principles makes the PHAM-CS uniquely suited to
promote systemic collaboration while incorporating
actionable strategies to achieve improved mental, phys-
ical, social, and ﬁnancial outcomes among cancer survi-
vors. The domains and strategies in the NAPCS were the
result of an iterative process of consensus agreement
among more than 100 experts in public health and cancer
survivorship.3 CDC developed the PHAM-CS through a
deliberative process of a team with expertise in cancer
survivorship and public health research, programmatic
initiatives, and policy efforts. The PHAM-CS acknowl-
edges the efforts of public health stakeholders at the
various levels and provides opportunities to improve
quality, outcomes, and potential sustainability of
their work.
Major components of the PHAM-CS (Figure 1) illus-
trate the levels of the SEM at which key stakeholder
groups have inﬂuence: NAPCS domains that promote
action in core public health areas (levers); the importance
of collaboration, cultural competence, evidence-based
interventions, and innovation in enhancing survivorship
initiatives (drivers); and foundational principles that
include concepts of behavioral change, evaluation, and
dissemination/implementation, which support the other
PHAM-CS components.
The levers—NAPCS domains—enable effective imple-
mentation of survivorship activities that impact survi-
vors, family, caregivers, providers, and others working at
the interpersonal level; health system, insurers, or other
organizations addressing the needs of cancer survivors;
community organizations such as local afﬁliates of
advocacy organizations, support groups, or community
health workers; and state, local, or national policies or
guidelines. The levers, representing NAPCS strategies,enable stakeholders working across the SEM to address
priority survivorship needs in the major public health
domains.
Drivers can enhance the reliability and validity of the
approaches being used by individuals working across
SEM levels and may maximize PHAM-CS’s effect on
intermediate and longer-term outcomes. Collaboration
between and among organizations may positively inﬂu-
ence and facilitate change at the various levels. Evidence-
based methods and programs need to be used and, when
appropriate, public health efforts need to be culturally
competent to effectively address factors that contribute to
differences in survivor outcomes.19 The PHAM-CS
illustrates a paradigmatic approach to address the needs
of cancer survivors by fully integrating the SEM and the
NAPCS domains into a system that acknowledges the
importance of collaboration, the use of evidence, cultural
competency, and innovation. This system is further
optimized through behavioral change, dissemination
and implementation, and evaluation.
The ﬁrst principle, behavioral change (explained by
theories of organizational behavior),20,21 may require
stakeholders to think globally and inclusively about their
work. Behavioral change would require support of an
ideology22 that collaboration across disciplines and levels
is necessary to facilitate progress in the area of survivor-
ship in which these stakeholders (e.g., organizations) are
currently working. This foundational principle encour-
ages and challenges stakeholders to think of their work as
part of a larger interconnected system. These connections
may exist between stakeholders who were not previously
identiﬁed as usual allies.
The second principle, dissemination and implementa-
tion, assumes that the work conducted in this integrative
framework will, when appropriate, be designed with thewww.ajpmonline.org
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tice.23,24 Speciﬁcally, collaborators will support the appli-
cation of evidence-based interventions. Dissemination
and implementation are bidirectional activities—
research informs program practice, and program practice
helps identify gaps in the knowledge base and spurs the
development of a research agenda.23,24 These activities
can support efforts to develop programs that are speciﬁc
for survivors and increase opportunities for sustainability
and scalability.23–25
Evaluation, the third foundational principle, requires
action to be taken to systematically monitor and collect
information on survivorship activities and outcomes.26
These efforts will support program improvement, assess
program effectiveness, and aid informed decision
making about the future of survivorship activities.
The third principle also requires a commitment to
establish indicators to monitor process and progress over
time.27Capacity for Public Health Action Model for Cancer
Survivorship Implementation
Public health organizations are uniquely positioned to
operationalize PHAM-CS. The application of research
for the public good is a core function of public health and
this goal is exempliﬁed by partnerships with diverse
groups of stakeholders at the various SEM levels. One
example of the capacity of the public health community
to implement PHAM-CS is comprehensive cancer con-
trol,28 an integrated approach to addressing the burden
of cancer in the U.S. This approach is evident in CDC’s
National Comprehensive Cancer Control Program
(NCCCP) and the Comprehensive Cancer Control
National Partnership, a network of 15 national organ-
izations that provide ongoing support to coalitions that
work collaboratively with NCCCP grantees.29 The
NCCCP funds all states, the District of Columbia, several
tribes and tribal organizations, and U.S. Afﬁliated Paciﬁc
Island jurisdictions to convene a diverse group of stake-
holders to form collaborative and comprehensive part-
nerships with the goal of developing and implementing
cancer plans to address issues within their respective
geographic areas. Core activities of the NCCCP include
use of cancer surveillance data to inform program
practice; maintenance of partnerships uniquely posi-
tioned to implement the plan; implementation of cancer
plan strategies that facilitate policy, system, and environ-
mental changes that promote primary prevention of
cancer, facilitate screening and treatment, and address
the needs of cancer survivors; and demonstration of
outcomes through evaluation.30 The Comprehensive
Cancer Control National Partnership also providesDecember 2015technical assistance and training to support partnership
building and use of evidence-base strategies to attain
goals related to increasing colorectal cancer screening,
human papillomavirus vaccinations, and tobacco cessa-
tion among cancer survivors.29 NCCCP grantees have
coalitions that consist of organizations that work across
the SEM levels, and grantees work collaboratively with
these organizations to implement survivorship activities
that are based on the NAPCS. Recent assessment of these
grantees found that 64% included recommended NAPCS
strategies in their program action plan.30 The NCCCP’s
broad-based partnerships. composed of representatives
working across all levels of the SEM,30 current endorse-
ment of NAPCS strategies, and implementation of core
activities provide opportunities for this public health
program to implement the PHAM-CS.31–33
Another example that highlights the applicability of
the PHAM-CS is CDC’s research, program, and media
campaign efforts to support initiatives for young breast
cancer survivors. CDC convened federal advisory com-
mittees comprising a diverse group of stakeholders to
address the burden of breast cancer among women
diagnosed before age 50 years.34 CDC worked collabo-
ratively with partners to employ activities across all
NAPCS domains to develop a research agenda that
informs program practice,35 implement programs and
media campaigns,36 conduct research and evaluation to
inform relevant initiatives,37,38 and lead ongoing evalua-
tions that assess effectiveness.39,40Operationalizing the Public Health Action Model for
Cancer Survivorship and Implications for Use
Full implementation of the PHAM-CS requires organiza-
tional behavior change that seeks collaborative relation-
ships with stakeholders working across SEM levels, a
commitment to facilitating the translation of research
into practice, and organizational support for and empha-
sis on evaluation. The model encourages individuals,
interpersonal networks, organizations, communities, and
policymakers across all levels and sectors to focus on the
priority public health domains, or levers, and the
associated NAPCS strategies. This critical work is best
supported in a collaborative environment, which strives
to implement activities that are evidence-informed,
culturally competent, and innovative.
Activities associated with surveillance offer an instruc-
tive example. Those conducting surveillance are encour-
aged to seek out innovative ways to ensure that data are
routinely used to inform research, program practice,
service delivery, and policy development. Their activities
may be enhanced by establishing partnerships with
organizations that work across the SEM levels but may
Moore et al / Am J Prev Med 2015;49(6S5):S470–S476S474not traditionally partner with organizations that admin-
ister surveillance systems.
To stimulate behavior change among stakeholders and
facilitate implementation of the model, surveillance
activities could be seen as an integral step to furthering
research, programs, and policies and providing a founda-
tion for effective and informed initiatives. Surveillance
organizations may adopt strategies that ensure that data
systems are available for widespread use, encourage
innovative use of high-quality data, and assure the results
of these efforts are disseminated broadly. This may
require providing technical assistance and training to
organizations that may not currently use high-quality
surveillance data to inform their work. Surveillance is an
important lever that can be used to assess progress toward
realizing improved outcomes among cancer survivors.
The PHAM-CS model can expand and enhance
research in the area of cancer survivorship by compelling
researchers to engage with programmatic and commun-
ity stakeholders and seek out collaborations with other
individuals working across the SEM levels. Research
organizations could beneﬁt from using traditional stake-
holder engagement strategies seen in community-based
participatory research as well as expand their relation-
ships to those that develop programs and policy. This
support may come in the form of expanding pre-existing
Communities of Practice to include programmatic and
community stakeholders or providing technical assis-
tance and trainings through initiatives like the Cancer
Prevention and Control Research Network (cpcrn.org/).
Researchers could continue to collaborate with program
implementers and evaluators to assess how research is
informing program practice.
Public health programs have great potential to make
notable contributions to the area of survivorship. Although
these programs have multiple partnerships with the capacity
to develop and implement cancer survivorship strategies
that are aligned with PHAM-CS levers, it is important that
interventions are based on current surveillance data,
research, and policy. Programs are also encouraged to
continue to evaluate their efforts and identify opportunities
for research, surveillance, and policy development.
The PHAM-CS also encourages collaboration with
those who develop public health policy and guidelines for
cancer survivors. Policy development and implementa-
tion are often dependent on economic, political, and
societal contextual factors. Expansion of partnerships
between organizations engaged in research, surveillance,
and program development may facilitate sustainable
policies and guidelines. The PHAM-CS calls for a
commitment to create collaborations that result in an
integrated, coordinated response to the needs of cancer
survivors.Broad Application of the Public Health Action Model
for Cancer Survivorship
Though PHAM-CS was created to facilitate approaches
to attain HP 2020 cancer survivorship objectives, core
elements of the PHAM-CS model (SEM levels, founda-
tional principles, levers, and drivers) can be applied to
future public health initiatives that address other chronic
disease conditions. The SEM and foundation principles
(behavioral change, dissemination/implementation, and
evaluation) are concepts extensively used in public
health, especially in chronic disease prevention and
control. The NAPCS strategies also resonate with public
health organizations working on chronic disease con-
ditions. Recent work by CDC identiﬁes epidemiology and
surveillance to monitor trends and inform programs,
environmental approaches that promote health and
support healthy behaviors, health system interventions
to improve the effective use of clinical and other
preventive services, and community resources linked to
clinical services that sustain improved management of
chronic conditions as viable approaches to address
chronic disease.41 Public health uses HP 2020 to monitor
and evaluate progress made toward meeting health
outcome objectives. Each component described in
PHAM-CS can be used and adapted to address other
chronic diseases. Organizations that address public
health concerns related to heart disease, diabetes, and
tobacco use may have the infrastructure and capacity to
implement the model through their partnerships, pro-
grams, research, and policy ofﬁces.
The PHAM-CS represents the implementation of
NAPCS strategies in an environment in which public
health works collaboratively with key stakeholders to
effect change at the survivor, interpersonal, organiza-
tional, community, and policy levels with the aim of
increasing the quality of life and survival rate of cancer
survivors. This integrated model can support changes
in multiple areas addressed by public health because
its components reﬂect the needs of research and
program constituents. Possibly the most signiﬁcant
challenge in implementing the PHAM-CS is the
investment and commitment of organizations to work
collaboratively and effectively to focus on distal out-
comes. Organizations that make this commitment
may make notable, lasting contributions to improving
the health status and QOL of individuals diagnosed
with cancer.Publication of this article was supported by the Centers for
Disease Control and Prevention, Division of Cancer Preven-
tion and Control.www.ajpmonline.org
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